Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.
Therapeutic advances in medical oncology(2023)
摘要
While increasing panel breadth beyond two tracked variants improved variant re-detection in ctDNA samples from patients with treatment refractory mCRC, increases beyond four tracked variants yielded no significant improvement in variant re-detection.
更多查看译文
关键词
circulating tumor DNA, colorectal cancer, ctDNA panel breadth, number of variants tracked, monitoring tumor burden
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要